Showing results (581-590 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|August 29, 2024
Pharmacodynamic Activity of [18F]-Fluorthanatrace Poly(ADP-ribose) Polymerase Positron Emission Tomography in Patients With BRCA1/2-Mutated Breast Cancer Receiving TalazoparibLilie L Lin, Franklin Wong, Ruitao Lin, et al.
JCO Precision Oncology|August 29, 2024
Real-World Biomarker Test Ordering Practices in Non-Small Cell Lung Cancer: Interphysician Variation and Association With Clinical OutcomesJason M Baron, Sarrah Widatalla, Matthew A Gubens, et al.
JCO Precision Oncology|September 4, 2024
Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown PrimaryHarry E Fuentes Bayne, Pashtoon M Kasi, Li Ma, et al.
JCO Precision Oncology|August 23, 2024
Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is TransientFlorence T H Wu, James T Topham, Chris J O'Callaghan, et al.
JCO Precision Oncology|August 29, 2024
False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring ATM and CHEK2 MutationsJaleh Fallah, Jianjin Xu, Hee-Koung Joeng, et al.
JCO Precision Oncology|December 3, 2024
Multigene Copy Number Alteration Risk Score Biomarker-Based Enrichment Study Designs in Metastatic Castrate-Resistant Prostate CancerYeonjung Jo, Jonathan J Chipman, Benjamin Haaland, et al.
JCO Precision Oncology|July 10, 2024
Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol AScott N Gettinger, Zihe Song, Karen L Reckamp, et al.
JCO Precision Oncology|July 8, 2024
Midline Low-Grade Gliomas of Early Childhood: Focus on Targeted TherapiesLudmila Papusha, Margarita Zaytseva, Agnesa Panferova, et al.
JCO Precision Oncology|July 8, 2024
Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor GenomicsWendy Kohlmann, David A Nix, Kristen Pauley, et al.
JCO Precision Oncology|July 8, 2024
Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective StudyYael Kusne, Terra Lasho, Christy Finke, et al.
Pageof 140